Skip to main content
OpenTrials

Clinical trial condition

Metastatic Pancreatic Cancer

Explore clinical trials studying Metastatic Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

131 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Pancreatic Cancer trial results

Active, Not Recruiting

Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)

NCT05642962

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +18 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer

NCT06168812

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +11 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC

NCT06059001

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Hospital Vall d´Hebrón Barcelona, Spain
  • ICO Hopsitalet L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain
  • Hospital Gregorio Marañon Madrid, Spain
View Trial Details
Active, Not Recruiting

A PhaseⅠStudy of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer

NCT06532331

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Aichi Cancer Center Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
  • Kanazawa University Hospital Kanazawa, Ishikawa-ken, Japan
  • Kanagawa Cancer Center Yokohama, Kanagawa, Japan
View Trial Details
Active, Not Recruiting

An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer

NCT06532344

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
  • Kanagawa Cancer Center Yokohama, Kanagawa, Japan
  • Seirei Hamamatsu General Hospital Hamamatsu, Shizuoka, Japan
  • Juntendo University Hospital Bunkyō-Ku, Tokyo, Japan
View Trial Details

Related conditions